Klingman & Associates, LLC
Source: SEC Form 13F · as of Mar 2026Klingman & Associates, LLC holds 17 biotech & pharma companies tracked by BioSniper, totaling $17.6M in value as of Mar 2026 (SEC Form 13F).
Companies held
17
Total value held
$17.6M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 18,072 | $4.4M |
| ABBVAbbVie Inc. | 13,120 | $2.9M |
| LLYELI LILLY & Co | 2,311 | $2.1M |
| ABTABBOTT LABORATORIES | 12,164 | $1.2M |
| MRKMerck & Co., Inc. | 10,297 | $1.2M |
| PMPhilip Morris International Inc | 6,325 | $1.0M |
| PFEPFIZER INC | 28,450 | $799K |
| AMGNAMGEN INC | 2,097 | $738K |
| NVSNovartis AG | 4,293 | $656K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 1,866 | $505K |
| GILDGILEAD SCIENCES, INC. | 2,645 | $369K |
| AZNASTRAZENECA PLC | 1,574 | $310K |
| REGNREGENERON PHARMACEUTICALS, INC. | 391 | $302K |
| GEHCGE HealthCare Technologies Inc. | 3,985 | $284K |
| MCKMcKesson Corporation | 291 | $252K |
| BMYBRISTOL MYERS SQUIBB CO | 4,114 | $250K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 529 | $236K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.